These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6740571)

  • 21. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads.
    Aihara M; Takami H; Sawada Y; Morimoto S; Kariya K; Kudo I; Ueno K; Kimura A; Yoshida Y
    Thromb Res; 1986 Dec; 44(5):661-72. PubMed ID: 3101223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis.
    Kłoczko J; Wojtukiewicz M; Bielawiec M; Zuch A
    Thromb Res; 1988 Sep; 51(6):575-81. PubMed ID: 3187967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels.
    Carr ME; Gabriel DA; McDonagh J
    J Lab Clin Med; 1987 Dec; 110(6):747-52. PubMed ID: 2890701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagen matrix-bound clotting factors (CMBCF) promote healing-associated events independent of factor XIII in an in vitro model.
    Pohle T; Becker JC; Lügering A
    Wound Repair Regen; 2011 Nov; 19(6):687-92. PubMed ID: 22092839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration.
    Lanir N; Ciano PS; Van de Water L; McDonagh J; Dvorak AM; Dvorak HF
    J Immunol; 1988 Apr; 140(7):2340-9. PubMed ID: 3351302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of indomethacin, dissolved in dehydrocholic acid, on fibrolysis, fibrin solidification phase and thrombocyte aggregation].
    Holzhüter H; Wenzel E; Angelkort B
    Verh Dtsch Ges Inn Med; 1974; 80():1439-42. PubMed ID: 4454449
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII.
    Keski-Oja J; Mosher DF; Vaheri A
    Cell; 1976 Sep; 9(1):29-35. PubMed ID: 975239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrin sealants in supporting surgical techniques: strength in factor XIII.
    Phillips M; Dickneite G; Metzner H
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():13-6. PubMed ID: 12869983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking.
    Weiss E; Yamaguchi Y; Falabella A; Crane S; Tokuda Y; Falanga V
    J Cell Physiol; 1998 Jan; 174(1):58-65. PubMed ID: 9397156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor XIII improves platelet adhesion to fibrinogen by protein disulfide isomerase-mediated activity.
    Lahav J; Tvito A; Bagoly Z; Dardik R; Inbal A
    Thromb Res; 2013 Apr; 131(4):338-41. PubMed ID: 23276530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XIII is not involved in human platelet-collagen interaction.
    Aihara M; Sawada Y; Takami H; Kariya K; Kudo I; Kimura A; Yoshida Y
    Tohoku J Exp Med; 1989 Sep; 159(1):37-44. PubMed ID: 2815074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.
    Bruhn HD; Bernsmeier R; Lück P; Zurborn KH; Christophers E
    Klin Wochenschr; 1983 Feb; 61(4):209-11. PubMed ID: 6573546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombin, factor XIII and fibronectin as regulators of the proliferation of tumor cells and vascular wall cells].
    Bernsmeier R; Holzgrebe E; Lück P; Bruhn HD; Zurborn KH
    Onkologie; 1983 Feb; 6(1):4-7. PubMed ID: 6341911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibronectin-based masking molecule blocks platelet adhesion.
    Geho DH; Smith WI; Liotta LA; Roberts DD
    Bioconjug Chem; 2003; 14(4):703-6. PubMed ID: 12862420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of factor XIII on the fibrosing of a nerve anastomosis in the rat.
    Herter T; Anaguostopoulos-Schleep J; Windmann D
    Res Exp Med (Berl); 1989; 189(1):25-32. PubMed ID: 2469114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antithrombotic action of nicotinic acid].
    Baluda VP; Eristavi ZA; Sushkevich GN
    Kardiologiia; 1974 Nov; 14(11):105-7. PubMed ID: 4139303
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.